Iron withholding: A defense against disease

Journal of Alzheimer's Disease

Volumn 13, Issue 4, 2008, Pages 451-463

  Weinberg, Eugene D ^a   Miklossy, Judith ^b  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease; Bacteria; Cardiovascular disease; Cerebrovascular disease; Dementia; Infectious disease; Iron; Iron withholding defense; Neoplastic disease; Neurodegenerative disorders

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; EPIGALLOCATECHIN GALLATE; FERRITIN; IRON; IRON CHELATING AGENT; LACTOFERRIN; RECOMBINANT PROTEIN; TRANSFERRIN; VK 28;

ALZHEIMER DISEASE; ARTHROPATHY; BEHAVIOR; BLOOD DONOR; CARDIOMYOPATHY; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; DEMENTIA; ENDOCRINE DISEASE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FRIEDREICH ATAXIA; HEREDITY; HUMAN; INFECTION; IRON INTAKE; IRON OVERLOAD; NEOPLASM; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 47849117134     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-13409     Document Type: Review

References (151)

1. P.A. Adlard and A.I. Bush, Metals and Alzheimer's disease, J Alzheimer's Dis 10 (2006), 145-163.
2. R. Agarwal, Proinflammatory effects of iron sucrfose in chronic kidney disease, Kid Internat 69 (2006), 1259-1263.
3. G. Bartzokis, T.A. Tishler, P.H. Lu, P. Villablaneva, L.L. Altschuiler, M. Carter, D. Huang,N. Edwards and J. Mintz, Brain ferritin iron may influence age- and gender-related risks of neurodegeneration, Neurobiol Aging 28 (2007), 414-423.
4. S. Basu, M.L. Mohan, X. Luo, B. Kundu, Q. Kong, and N. Singh, Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox Iron implications for prion replication and disease pathogenesis, Molec Biol Cell 18 (2007), 3302-3312.
5. L.E. Beckman, G.F. Van Landegham, C. Sikstrom, A. Wahlin, B. Markevarn, G. Hallmans, P. Lenner, L. Athlin, R. Stenling and L. Beckman, Interaction between hemochromatosis and transferring receptor genes in different neoplastic disorders, Carcinogenesis 20 (1999), 1231-1233.
6. D. Ben-Shachar, N. Kahana, V. Kampel, A. Warshawsky and M. B. Youdim, Neuroprotection by a noivel iron permeable chelator, VK-28, against 6-hydroxydopamine lesions in rats. Neuropharmacology 46 (2004), 254-263.
7. D. Berg and H. Hochstrasser, Iron metabolism in Parkinson's syndrome, Movement Dis 21 (2006), 1299-1310.
8. D. Berg and M.B. Youdim, Role of iron in neurodegenerative disorders. Top Magn Reson Imaging 17 (2006), 5-17.
9. M. Berkovitch, T. Bistritzer, S. D. Milone, K. Perlman, W. Kucharczyk and N. F. Olivieri, Iron deposition in the anterior pituitary in homozygous beta-thalassemia: MRI evaluation and correlation with gonadal function, J PedEndocrinol Metab 13 (2000), 179-184.
10. G.M. Bishop, S.R. Robinson, Q. Liu, G. Perry, C.S. Atwood and M.A. Smith, Iron: a pathological mediator of Alzheimer disease? Dev Neurosci 24 (2002), 184-187.
11. N. Birch, X. Wang and H-S. Chong, Iron c helators as therapeutic iron depletion agents, Expert Opin Ther Patents 16 (2006), 1533-1556.
12. N. Boddaert, K.H.L.Q Sang, A. Rotig, A. Leroy-Willig, S. Gallet, F. Brunelle, D. Sidi, J.-C. Thalabard, A. Munnich and Z.L. Cabantchik, Selctive iron chelation In Friedriech's ataxia. Biological and clinical implications, Blood 110 (2007), 401-408.
13. H.L. Bonkovsky and G.V. Barnard, The porphyrias, Curr Treat Options Gastroenterol 3 (2000), 487-500.
14. A.I. Bush, Metals and neuroscience, Curr Opin Chem Biol 4 (2000), 184-191.
15. J.R. Butterworth, Another important function for an old friend! The role of iron in colorectal carcinogenesis, Gut 55 (2006), 33-35.
16. R.L. Castellani, P.J. Moreira, G. Liu, J. Dobson, G. Perry, M.A. Smith and X. Zhu, Iron, the redox-active center of oxidative stress in Alzheimer Disease, Neurochem Res 32 (2007), 1640-1645.
17. J.P. Chern, K.H. Lin, M.Y. Lu, D.T. Lin, K.S. Lin, J.D. Chen and C.C. Fu, Abnormal glucose tolerance in transferrin-dependent beta-thalassemia patients, Diab Care 24 (2001), 850-854.
18. E. Cho, Y. Chen, D.J. Hunter, M.J. Stampfer, G.A. Colditz, S.E. Haakinson and W.C. Willett, Red meat intake and risk of breast cancer among premenopausal women, Arch Intern Med 166 (2006), 2253-2259.
19. I. Chowens, R. Wong, T. Dentchev, R.H. Farkas, J. Iacovelli, J. Gunatilaka, N.E. Madeiros, J.E. Presley, P.A. Campochiaro, C.A. Curcio, J.L. Dunaief and D.J. Zack, The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration, Invest Ophthalmol Visual Sci 47 (2006), 2135-2140.
20. J.F. Collingwood, A. Mikhaylova, M. Davidson, C. Batich, W.J. Streit, J.Terry and J. Dobson, In situ characterization and mapping of iron compounds in Alzheimer's disease tissue, J Alzheimer's Dis 7 (2005), 267-272.
21. J. Collingwood, J. Dobson, Mapping and characterization of iron compounds in Alzheimer's tissue, J Alzheimer's Dis 10 (2006), 215-222.
22. J.R. Connor and S.Y. Lee, HFE mutations and Alzheimer's disease, J Alzheimer's Dis 10 (2006), 267-276.
23. J.R. Connor S.L. Menzies, S.M. St Martin and E.J. Mufson, A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains, J Neurosci Res 31 (1992), 75-83.
24. V.C. Culotta, M. Yang and T.V. O'Halloran, Activation of superoxide dismutases: putting the metal to the pedal, Biochim Biophys Acta 1763 (2006), 747-758.
25. R. Danzeisen, T. Achsel, U. Bederke, M. Cozzolino, C. Crosio, A. Ferri, M. Frenzel, E.B. Gralla, L. Huber, A. Ludolph, M. Nencini, G. Rotilio, J.S. Valentine and M.T. Carrì, Superoxide dismutase 1 modulates expression of transferrin receptor, J Biol Inorg Chem 11 (2006), 489-498.
26. S. Defrere, A. Van Langendonct, S. Vaesen, M. Jouret, R.G. Ramos, D. Gonzalez and J.I. Donnez, Iron overload enhances epithelial cell Proliferation in endometriotic lsions induced in a murine model, Hum Reprod 21 (2006), 2810-2816.
27. S. Denic and M.M. Agarwal, Nutritional iron deficiency: an evolutionary perspective, Nutrition 23 (2007), 603-661.
28. R.G. DePalma, V.W. Hayes and L.R. Zacharski, Bloodletting, past and present, J Am Call Surg 205 (2007), 132-144.
29. V. DeSanctis, Growth and puberty and its management in thalassemia, Hormone Res 58(suppl. 1) (2002), 850-854.
30. A.M. Di Biscegli, H.L. Bonkovsky, S. Chopra, S. Flamm, R.K. Reddy, G.H. Killenberg, P. Hunt, C. Tamburro, A.S. Tavill, R. Ferguson, E. Krawitt, B. Banner and B. R. Bacon, Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon; a multicentre, randomized, controlled trial, Hepatology 32 (2000), 135-138.
31. M.T. Dorak, HFE H63D variant and leukemia susceptibility, Leuk Lymphoma 47 (2006), 2269-2270.
32. S. Dubois and K.V. Kowdley, Reviewarticle: targeted screening for hereditary hemochromatosis in high risk groups, Aliment Pharmacol Ther 20 (2004), 1-14.
33. J.E. Eby, H. Sato and D.A. Sirbasku, Apotransferrin stimulation of thyroid hormone dependent rat pituitary tumor cell growth in serum-free chemically defined medium: role of Fe(II) chelation, J Cell Physiol 156 (1993), 588-600.
34. C.Q. Edwards, T.M. Kelly, C. Ellwein and K.P. Kushner, Thyroid disease in hemochromatosis: increased incidence in homozygous men, Arch Intern Med 143 (1983), 1890-1893.
35. J.T. Egaña, C. Zambrano, M.T. Nuñez, C. Gonzalez-Billault and R.B. Maccioni, Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures, Biometals 16 (2003), 215-223.
36. C. Ellervik, T. Mandrup-Poulsen and B.G. Nordestgaard, Prevalence of hereditary hemochromatosis in late onset type 1 diabetes mellitus: a retrospective study, The Lancet 358 (2001), 1405-1409.
37. C. Ellervik, A. Tybj aerg-Hansen, M. Appleyard, T.H. Sillesen, G. Boysen and B.G. Nordestgaard, Hereditary hemochromatosis genotypes and risk of Ischemic stroke, Neurology 68 (2007), 1025-1031.
38. C. Exley, Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta {42} in senile plaque cores in Alzheimer's disease, J Alzheimers Dis 10 (2006), 173-177.
39. S. Fargion, M. Mattioli, A.L. Francanzini, M. Sampietro, D. Tavazzi, P. Fociana, E.M. Taioli, I. Valenti and G. Fiorelli, Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis, Am J Gastroenterol 96 (2001), 2448-2455.
40. G. Farrar, P. Altmann, S. Welch, 0. Wychrij, B. Ghoso, L. Lejeune, J. Corbett, V. Prasher and A. Blair, Defective gallium transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminum in the brain, The Lancet 335 (1990), 747-750.
41. D. Feifel and C.W. Young, Iron overload among a psychiatric population, J Clin Psychiatr 58 (1997), 74-78.
42. J.M. Fernandez-Real, A. Lopez-Bermejo and W. Ricart, Cross-talk between iron metabolism and diabetes, Diabetes 51 (2002), 2348-2354.
43. J.M. Fernandez-Real, G. Pennaroja, A. Castro, F. Garcia-Bragado, A. Lopez Bermajo and W. Ricart, Blood letting in high-ferritin type 2 diabetes - effects on vascular reactivity, Diab Care 25 (2002), 2249-2255.
44. D.J. Fleming, K.L. Tucker, P.F. Jacques, G.E. Dallal, P.W.F. Wilson and R.J. Wood, Dietary factors associated with the risk of high iron stores in the elderly. Framingham heart study cohort, Am I Clin Nutr 76 (2002), 1375-1384.
45. A. Forge and J. Schacht, Aminoglycoside antibiotics, Audiol Neuroontol 5 (2000), 3-22.
46. A. Furst, Metals in tumors, in Metal Binding in Medicine, M.S. Seven and L.A. Johnson, eds, J.B. Lippincott Co., Philadelphia, 1960, pp. 329-324.
47. I.T. Gangaidzo, V.M. Mayo, E. Myundura, G. Aggrey, N.L. Murpree, H. Khumalo, T. Saungweme, I. Kasvosve, A.R.G. Zvenyika, T. Roualt, J.R. Boelaert and V.R. Gordeuk, Association of pulmonary tuberculosis with increased dietary iron, J Infec Dis 184 (2001), 936-939.
48. J.M. Geleijnse, L.J. Launer, D.A. Van der Kuip, A. Hofinan and J.G. Wittman, Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam study, Am J Clin Nutr 75 (2002), 880-886.
49. M. Gerlach, K.L. Double, M.B.H. Youdim and P. Riederer, Potential source of increased iron in the substantia nigra of parkinsonian patients, J Neural Transmission 70 (2006), 133-142.
50. A.J. Ghio, E.S. Ford, T.P. Kennedy and J.R. Hoidal, The association between serum ferritin and uric acid in humans, Free Radic Res 39 (2005), 337-342.
51. A.J. Ghio, J.L. Turi and M.C. Madden, L.A. Dailey, J.D. Richards, J.G. Stonehuerner, D.L. Morgan, S. Singleton, L.M. Garrick and M.D. Garrick, Lung injury after ozone exposure is iron-dependent, Am J Physiol Lung Cell Mol Physiol 292 (2006), L134-143.
52. O. Ghribi, M.Y. Golovko, B. Larsen, M. Shrag and E.J. Murphy, Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets, J. Neurochem 99 (2006), 438-449.
53. S. Giunta, R. Galeazzi, M.B. Valli, E.H. Corder and L. Galeazzi, Transferrin neutralization of amyloid beta 25-35 cytotoxicity, Clin Chim Acta 350 (2004), 129-136.
54. L. Goodman, Alzheimer's disease - a clinic-pathologic analysis of twenty-three cases with a theory on pathogenesis, J Nerv Ment Dis 118 (1953), 97-130.
55. A. Gregory and S.J. Hayflick, Neurodegeneration with brain iron accumulation, Folia Neuropathol 43 (2005), 286-296.
56. A. Gunel-Ozcan, S. Alyilmaz-Bekmez, E.N. Guler and D. Guc, HFE H63D mutation frequency shows an increase in Turkish women with breast cancer, BMC Cancer 6 (2000), 37.
57. P. Hahn, A.H. Milam and J.L. Dunaief, Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane, Arch Ophthalmol 121 (2003), 1099-1105
58. N. Hakobyan, T. Kazarian, A.A. Jabber, and L.A. Valentine, Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene, Blood 104 (2004), 2060-2064.
59. S.W. Hulet, S. Powers and J.R. Connor, Distribution of transferrin and ferritin binding in normal and multiple sclerotic brains, J Neurol Sci 165 (1999), 48-55.
60. M. Ikeda, Iron overload without the C282Y mutation in patients with epilepsy, J, Neurol. Neurosurg Psychiat 70 (2001), 551-553.
61. A.R. Kallianpur, L.D. Hall, M. Yadav, B.W. Christman, R.S. Dittus and L.L. Haines, Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer, Canc Epidemiol Biomarkers Prev 13 (2004), 205-212.
62. A.E.R. Kartikasari, N.A. Georgion, M. de Geest, J.H. van Kats-Renaud, J.J.M. Bouwman, B.S. van Asbeck, J.J.M. Marx and F.L.J. Viseren, Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection, Eur J Clin Invest 36 (2006), 743-752.
63. Y. Ke, Z.M. Qian, Brain iron metabolism: neurobiology and neurochemistry, Prog Neurobiol 83 (2007), 149-173.
64. Y. Ke and Z. Qian, Iron misregulation in the brain: a primary cause of neurodegenerative disorders, The Lancet Neurol 2 (2003), 246-253.
65. M.L. Kennard, H. Feldman, T. Yamada, W.A. Jefferies, Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease, Nat Med 2 (1996) 1230-1235.
66. I. Kochan, The role of iron in bacterial infection, Curr Top Microbial 60 (1973) 1-30.
67. D. Lapenna, G. Pierdomenico, S. Ucchino, M. Neri, M.A. Giamberardino and F. Cuccurullo, Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques, Free Rad Biol Med 42 (2007), 492-498.
68. D.W. Lee and J.K. Andersen, Role of HIF-1 in iron regulation: potential therapeutic strategy for neurodegenerative disorders, Curr Mol Med 6 (2006), 883-893.
69. S.V. Lee, S.M. Patton, R.J. Henderson and J.R. Connor, Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE, FASEB J 21 (2007), 564-576.
70. D.J. Lehmann, M. Worwood, R. Ellis, V.L. Wimhurst, A.T. Merryweather-Clarke, D.R. Warden, A.D. Smith and K.J. Robson. Iron genes, iron load and risk of Alzheimer's disease, J Med Genet 43 (2006), e52.
71. L. Lih-Brody, Increased oxidative stress and decreased antioxidant defense in mucosa of inflammatory bowel disease, Dig Dis Sci 41 (1996), 2078-2086.
72. C.W. Levenson and N.M. Tassabehji, Iron and ageing: an introduction to iron regulatory mechanisms, Ageing Res Rev 3 (2004), 251-263.
73. D. Luce, Environmental exposure to tremolite and respiratory cancer in New Caledonia: a case control study, Am J Epidemiol 151 (2000), 259-265.
74. J.M. McCord, Effects of positive iron status at a cellular level, Nutr Rev 54 (1996), 85-88.
75. A.G. Mainous III, B.J. Wells, P.J. Carek, J.M. Gilland and M.E. Geesey, The mortality risk of elevated serum transferrin saturation and consumption of dietary iron, A Fam Med nn 2 (2004), 139-144.
76. A.G. Mainous III, S.L. Eschenbach, B.J. Wells, C.J. Everett and J.M. Gill, Cholesterol, transferrin saturation and the development of dementia and Alzheimer's disease: results from an 18-year population-based cohort. Fam Med 37 (2005), 36-42.
77. A.G. Mainous, B.J. Wells, C.J. Everett, J.M. Gill and D.E. King, Association of ferritin and lipids with C-reactive protein, Am J Cardiol 93 (2004), 559-562.
78. E.A. Malecki and J.R. Connor, The case for iron chelation and/or antioxidant therapy in Alzheimer's disease, Drug Devel Res 56 (2002), 526-530.
79. Mattson MP. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders, Ann N Y Acad Sci 1012 (2004), 37-50.
80. M.A. McAteer, N.R. Sibson, C. von Zur Muhlen, J.E. Schneider, A.S. Lowe, N. Warrick, K.M. Channon, D.C. Anthony and R.P. Choudhury, In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide, Nat Med 13 (2007), 1253-1258.
81. H.H. Merritt, R.D. Adams, H.C. Solomon, Neurosyphilis, Oxford University Press, London, (1946).
82. S. Michael, S.V. Petrocine, J. Qian, J.B. Lamarche, M.D. Knutson, M.D. Garrick and A.H. Koeppen, Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia, Cerebellum 5 (2006), 257-267.
83. M. Milan, T. Sobrino, M. Castellanos, F. Nombela, J.F. Arenillas, E. Riva, I. Cristoboa, M.M. Garcia, J. Vivancos, J. Serena, M.A. Mom, J. Castillo and A. Davalos, Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke, Stroke 38 (2007), 90-95.
84. T. Moos and E.H. Morgan, The metabolism of neuronal iron and its pathogenic role in neurological disease: review, Ann N Y Acad Sci 1012 (2004), 14-26.
85. V.M. Moyo, R. Makunike, I.T. Gangaidzo, V.R. Gordeuk, C.E. McLaren, H. Kumalo, T. Saungweme, T. Roualt and C.F. Kline, African iron overload and hepatocellular carcinoma, Eur J Hematol 60 (1998), 28-34.
86. T. Naghibi, V. Ghafghazi, A. Hajhashemi, A. Talebi and D. Taheri, The effect of 2,3-dihydroxybenzoic acid and tempol in prevention of vancomyein-induced nephrotoxicity in rats, Toxicology 232 (2007), 192-199.
87. K. Namekata, M. Imagawa, A. Terashi, S. Ohta, F. Oyama and Y. Ihara, Association of transferrin C2 allele with lateonset Alzheimer's disease, Hum Genet 101 (1997), 126-129.
88. A.L. Nedlson, A.J. Ratner, J. Barasch and J.N. Weiser, Interleukin-8 secretion in response to aferric enterobactin is potentiated by siderocalin Infect Immun 75 (2007), 3160-3168.
89. R.L. Nelson, Iron and colorectal cancer risk: human studies, Nutr Rev 59 (2001), 140-148.
90. C. Niederau, R. Fisher, W. Sonnenberg, W. Stremmel, H.J. Trampisch and G. Strohmeyer, Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis, N Engl J Med 313 (1985). 1256-1262.
91. C. Obejero, T. Yang, W.Q. Dong, M.N. Levy, G.H. Brittenham, Y.A. Kuryshev and A.M. Brown, Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron overload cardiomyopathy, Clin Med 141 (2003), 121-130.
92. B. Oldenberg, J.C. Koningsberger, G.P. Van Berge-Henegouwen, B.S. van Asbeck and J.J. M. Marx, Review article: iron and inflammatory bowel disease, Aliment Pharmacol Ther 15 (2001), 429-438.
93. S.T. Ong, J.G.S. Ho, B. Ho and J.L. Ding, Iron-withholding strategy in innate immunity, Immunobiology 211 (2006), 295-314.
94. S.J. Oppenheimer, Iron and its relation to immunity and infectious disease, J Nutr 131 (2001), 616S-635S.
95. Y. Pawlotsky, P. LeDarter, R. Moirand, P. Guggenbuhl, A.M. Juanelle, E. Catheline, J. Meadeb, P. Brissot, Y. Deugnier and G. Chales, Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis, Arthr Rheum 42 (1999), 799-806.
96. C.G. Pham, C. Bubici, F. Zazzeroni, S. Papa, J. Jones, K. Alvarez, S. Jayawardena, E. De Smaele, R. Cong, C. Beaumont, F.M. Torti, S.V. Torti and G. Franzoso, Ferritin heavy chain upregulation by NF-kB inhibits TNFa-induced apoptosis by suppressing reactive oxygen species, Cell 119 (2004), 529-542.
97. A. Pietrangelo, Molecular insights into the pathogenesis of hereditary hemochromatosis, Gut 55 (2006), 564-568.
98. D.J. Piñero, J. Hu and J.R. Connor, Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains, Cell Mol Biol (Noisy-le-grand) 46 (2000), 761-776.
99. A. Piperno, P. Trombini, M. Gelosa, V. Mauri, V. Pecci, A. Vergani, A. Salvioni, R. Mariani and G. Mancia, Increased serum ferritin is common in men with essential hypertension, J Hypertens 20 (2002), 1513-1518.
100. D. Ponraj, J. Makjanik, P.S. Thong, B.K. Tan and F. Watt, The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion, FEBS Lett 459 (1999), 218-222.
101. M.P. Rayman, J. Barlis, R.W. Evans, C.W.G. Redman and L.J. King, Abnormal iron parameters in the pregnancy syndrome pre-eclampsia, Am I Obstet Gynecol 187 (2002), 412-418.
102. D.W. Reid, Q.T. Lam, H. Schneider and E.H. Walters, Airway iron and iron-regulatory cytokins in cystic fibrosis, Eur Respir J 24 (2004), 286-291.
103. L. Reznichenko, T. Amit, H. Zheng, Y. Avramovich-Tirosh, M.B. Youdim, O. Weinreb and S. Mandel, Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease, J Neurochem 97 (2006), 527-536.
104. D.R. Richardson, Friedreich's ataxia: iron chelators that target the mitochondrion as a therapeutic strategy? Expert Opin Invest Drugs 12 (2003), 235-245.
105. J.P. Robinson, V.L. Johnson, P.A. Rogers, R.S. Houlston, E.R. Maher and D.T. Bishop, Evidence for an association between compound heterozygosity for germ line mutations in the hemochromatosis (HFE) gene and increased risk of colorectal cancer, Canc Epidemiol Biomarkers Prev 14 (2005), 1460-1463.
106. K.J. Robson, D.J. Lehmann, V.L. Wimhurst, K.J. Livesey, M. Combrinck, A.T. Merryweather-Clarke, D.R. Warden and A.D. Smith, Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer's disease, J Med Genet 41 (2004), 261-265.
107. C. Roth, A. Pekrum, M. Barts, H. Jarry, S. Eber and M. Lakomek, Short stature and failure of pubertal development in thalassemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion, Eur J Ped 156 (1997), 777-783.
108. M. Sacharczuk, T. Zagulski, B. Sadowski, M. Barcikowska and R. Pluta, Lactoferrin in the central nervous system, Neurol Neurochir Pol 39 (2005), 482-489.
109. S. Sazawal, R.E. Black, M. Ramsan, H.M. Chwaya, R.J. Stoltzfus, A. Dutta, U. Dhingra, I. Kabole, S. Deb, M.K. Othman and F.M. Kabole, Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomized, placebo-controlled trial, The Lancet 367 (2006), 133-443.
110. H.R. Schumacher, P.C. Strake, M.A. Krikker and A.T. Dudley, The arthropathy of hemochromatosis, Ann NY Acad Sci 526 (1988), 224-233.
111. N.J. Shaheen, L.M. Silverman, T. Keku, L.B, Lawrence, E.M. Rohifs, G.F. Martin, J. Galanko and R.S. Sandler, Assiociation between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer, J Natl Canc Inst 95 (2003), 154-159.
112. I. Shcherbatykh and D.O. Carpenter, The role of metals in the etiology of Alzheimer's disease, J Alzheimers Dis 11 (2007), 191-205.
113. D.A. Simmons, M. Casale, B. Alcon, N. Pham, N. Narayan and G. Lynch, Ferritin accumulation in dystrophic microglia is an early event in the development of Huntington's disease, Glia 55 (2007), 1-7.
114. T. Simonart, Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma, Canc Lett 244 (2006), 1-7.
115. N. Stadler, R.A. Lindner and M.J. Davies, Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper,Arterioscler Thromb Vasc Biol 24 (2004), 949-954.
116. J. Stankiewicz, S.S. Panter, M. Neema, A. Arora, C.E. Batt and R. Bakshi, Iron in chronic brain disorders: imaging and neurotherapeutic implications, Neurotherapeutics 4 (2007), 371-386.
117. J.L. Sullivan, Macrophage iron, hepcidin, and atherosclerotic plaque stability, Exp Biol Med 232 (2007), 1014-1020.
118. J.L. Sullivan and E.D. Weinebrg, Iron and the role of Chlamydia pneumoniae in heart disease, Emerging Infec Dis 5 (1999), 724-726.
119. S. Swaminathan, M.G. Alam, V.A. Fonseca and S.V. Shah, The role of iron in diabetes and its complications, Diab Care 30 (2007), 1926-1933.
120. A. Takeda, Essential trace metals and brain function, Yakugaku Zasshi 124 (2004), 577-585.
121. G.S. Teehan, D. Bandouch, R. Ruthazer, V.S. Balakrishnan, D.L. Syndman and B.L. Jaher, Iron storage indices: novel predictors of bacteremia in hemodialysis patients initiating intravenous iron therapy, Clin Infec Dis 38 (2004), 1090-1094.
122. K.I. Thompson, S. Shoham and J.R. Connor, Iron and neurologic disorders, Brain Res Bull 55 (2001), 155-164.
123. M.J. Tweed and J.M. Roland, Hemochromatosis as an endocrine cause of subfertility, Br Med J 316 (1998), 915-916.
124. A. Viola, L. Pagano, D. Laudati, R. D'Elia, M.R. D'Amico, M. Ammirabile, S. Palmieri, L. Prossomariti and F. Ferrara, HFE gene mutations in patients with acute leukemia, Leuk Lymphoma 47 (2000), 2331-2334.
125. L. Von Bonsdoiff, L. Sahlstedt, F. Ebeleing, T. Rutue and J. Parkkinen, Apotransferrin adminstrtation prevents growth of Staphylococcus epidermis in serum of stem cell transplant patients by binding free iron, FEMS Immunol Med Microbiol 37 (2003), 45-51.
126. X-S. Wang, S. Lee, Z. Simmons, P. Boyer, K. Scott, W. Liu and J.R. Connor, Increased incidence of the HFE mutation in amyotrophic lateral sclerosis and related cellular consequences, J Neural Sci 227 (2004), 27-33.
127. E.D. Weinberg, Iron withholding: a defense against infection and neoplasia, Physiol Rev 64 (1984), 65-102.
128. E.D. Weinberg, The role of iron in cancer, Eur J Canc Prev 5 (1996), 19-36.
129. E.D. Weinberg, Patho-ecological implications of microbial acquisition of host iron, Rev Med Microbiol 9 (1998), 171-178.
130. E.D. Weinberg, The role of iron in protozoan and fungal diseases. J Eukaryot Microbiol 46 (1999), 231-237.
131. E.D. Weinberg, Iron loading and disease surveillance, Emerging Infec Dis 5 (1999) 346-352.
132. E.D. Weinberg, The development of awareness of the carcinogenic hazard of inhaled iron, Oncol Resit (1999), 109-113.
133. E.D. Weinberg, Microbial pathogens with impaired ability to acquire host iron, BioMetals 13 (2000), 85-89.
134. E.D. Weinberg, Iron, infection and sudden infant death, Med Hypoth, 56 (2001), 731-734.
135. E.D. Weinberg, Iron and the role of Coxiella burnetii in heart disease, J Trace Elem Exp Med 14 (2001), 409-410.
136. E.D. Weinberg, Cardiovascular system, in: Exposing the Hidden Dangers of Iron, C. Garrison, ed., Cumberland Press, Nashville, pp. 89-98.
137. E.D. Weinberg, Iron withholding as a defense strategy, in: Anemia of Chronic Disease, E. Weiss, V.R. Gordeuk and C. Hershko, eds, Taylor and Francis, Boca Raton, pp. 255-280.
138. E.D. Weinberg, Iron loading: a risk factor for osteoporosis, BioMetals 19 (2006), 633-635.
139. E.D. Weinberg, Iron loading in humans: a risk factor for enhanced morbidity and mortality, J Nutr Environ Med 16 (2007), 43-51.
140. E.D. Weinberg, Antibiotic properties and applications of lactoferrin, Curr Pharmaceut Des 13 (2007), 801-811.
141. E.D. Weinberg, Survival advantage of the hemochromatosis C282Y mutation, Persp Biol Med 51 (2008), 98-102.
142. O. Weinreb, P. Amit and M.B. Youdim, A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate, Free Rad Biol Med 43 (2007), 546-556.
143. P.F. Whitington and J.U. Hibbard, High dose immunoglobulin during pregnancy for recurrent neonatal hemochromatosis, The Lancet 364 (2004), 1690-1698.
144. P. Whittake, P.R. Tufaro and J.J. Rader, Iron and folate in fortified cereals, J Am Coll Nutr 20 (2001), 247-254.
145. J.G. Wilson, J.H. Lindquist, S.C. Grambow, E.D. Crook and J.F. Maher, Potential role of increased iron stores in diabetes, Am J Med Sci 326 (2003), 332-339.
146. J.C. Wood, J.M. Tyszka, S. Carson, M.D. Nelson and T.D. Coates, Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease, Blood 103 (2004), 1934-1936.
147. A.S. Wu, M. Kiaei, N. Aguirre, J.P. Crow, N.Y. Calingasan, S.E. Browne and M.F. Beal, Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis, J Neurochem 85 (2003), 142-150.
148. P. Zamboni, M. Izzo, S. Tognazzo, S. Carandino, M. De-Palma, L. CatoM, A. Caggiati, G. Scapoli and D. Gemmati, The overlapping of local iron overload and HFE mutation in venous leg ulcer, Free Rad Biol Med 40 (2006), 1869-1873.
149. Q.I. Zhang and X.I. Huang, Induction of ferritin and lipid peroxidation by coal samples with different prevalence of coal workers' pneumoconiosis: The role of iron in the coals, Am J Med 42 (2002), 171-179.
150. X. Zhang, M. Haaf, B. Todorich, E. Grosstephan, H. Schieremberg, N. Surguladze and J.R. Connor, Cytokine toxicity to oligodendrocyte precursors is mediated by iron, Glia 52 2005, 199-208.
151. X. Zhu, B. Su, X. Wang, M.A. Smith and G. Perry, Causes of oxidative stress in Alzheimer disease, Cell Mol Life Sci 64 (2007), 2202-2210.